PHG Stock Analysis
NYQ · Healthcare · Medical Devices
$25.15
+0.19 (+0.76%)
PHG Interactive Price Chart & Trading Signals
PHG Stock Snapshot — Valuation, Risk & Technical Signals
PHG Key Fundamentals, Analyst Targets & Company Profile
Key Financial Ratios
Market Cap
$24.58B
P/E Ratio
19.35
Forward P/E
13.21
PEG Ratio
0.76
P/B Ratio
1.88
EPS
$1.30
Dividend Yield
4.06%
52W Range
$23.85 – $33.44
Beta
0.91
Volume
0.2M
ROE
10.2%
Profit Margin
6.3%
Revenue Growth
0.5%
Gross Margin
45.9%
EV/EBITDA
12.46
Analyst Target
$32.21
The trailing price-to-earnings ratio stands at 19.3x. Forward P/E of 13.2x implies earnings expansion expected. Price-to-book is 1.88x. EV/EBITDA sits at 12.46x. Market capitalization is $24.58B. Revenue is growing at 0.5% on a trailing basis. Earnings are expanding at 61.4%. Profit margins are 6.3%. Return on equity is 10.2%. Beta of 0.91 indicates market-average volatility.
Analyst Consensus
Recommendation
none
Low Target
$26.75
Mean Target
$32.21
High Target
$41.00
Based on 5 analysts
About PHG
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
PHG Deep Dive Analysis
Bottom Line
Verdict
UndervaluedBest for
Value-oriented investorsWatch out for
None flaggedNon-zero inputs
4/5Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.
Koninklijke Philips N.V. (PHG) trades below our multi-model fair value estimate of $33.02 by approximately 31.3%. Trailing P/E: 19.3x. Profitability signals include profit margin of 6.3% and return on equity of 10.2%. Recent growth metrics show revenue growth of 0.5% and earnings growth of 61.4%. Risk profile: beta of 0.91. Consensus: none.
Valuation, Growth & Risk
Valuation
Undervalued
P/E 19.3x
Price sits below our estimate of fair value.
Growth
Stable
Rev 0.5%
Revenue is moving sideways.
Valuation Snapshot
Koninklijke Philips N.V. (PHG) trades below our multi-model fair value estimate of $33.02 by approximately 31.3%. The trailing price-to-earnings ratio stands at 19.3x. Forward P/E of 13.2x suggests earnings compression ahead. Price-to-sales is 1.4x. Price-to-book is 1.9x. EV/EBITDA sits at 12.5x. Market capitalization is $24.58B.
Why it matters: Buying below fair value can create a margin of safety, but always check earnings quality.
Growth & Profitability
Revenue is growing at 0.5% on a trailing basis. Earnings are expanding at 61.4%. Profit margins are 6.3%. Return on equity is 10.2%. Return on assets is 4.1%.
Why it matters: Stable revenue is fine, but watch for margin pressure that could limit profit growth.
Risk Profile
Beta of 0.91 indicates market-average volatility. Net debt position is $5.68B.
Why it matters: Lower risk means steadier returns, but often with less upside in bull markets.
Analyst Context
Analyst consensus target of $32.21 implies 28.1% upside. Target range spans $26.75 to $41.00. 5 analysts cover the stock. Consensus recommendation: none.
Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.
Investor Fit
The combination of undervaluation and moderate risk may suit value-oriented investors.
Takeaway: Match the stock's risk-reward profile with your own goals and time horizon. No single metric tells the whole story.
Data Methodology & Sources
Market Data (Facts)
- Price, volume, and market cap: Yahoo Finance (may be delayed)
- P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
- Analyst estimates: Yahoo Finance (coverage and update times vary)
- Insider transactions: Yahoo Finance (reporting may be delayed)
QuantSoar Model (Derived)
- Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
- Margin of Safety = (Fair Value − Displayed Price) / Displayed Price × 100
- Composite Score: 40% Value + 30% Momentum + 30% Risk
- Verdict Gauge: Base 50 + Valuation (up to ±25) + Whale sentiment (up to ±10) + Insider buying (+5) + Macro risk (up to ±10) + Technical signal (up to ±10). Analyst consensus is separate.
Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.
PHG Undervalued
Koninklijke Philips N.V. (PHG) trades below our multi-model fair value estimate of $33.02 by approximately 31.3%.
Frequently Asked Questions
ValuationIs PHG stock overvalued right now?
ValuationWhat is PHG fair value based on current fundamentals?
RiskHow risky is PHG compared with other stocks?
GrowthIs PHG still growing?
AnalystWhat do analysts think about PHG?
DividendDoes PHG pay a dividend?
CatalystWhat could change the investment case for PHG?
Related Stocks
About the Author
Phasakorn Traklang (Peach) — Founder
Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.
Connect on LinkedInInvestment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC
Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.